JNK-IN-11
JNK-IN-11 (compound 1) is a potent JNK inhibitor with an IC50 value of 2.2, 21.4, 1.8 µM for JNK1, JNK2, JNK3, respectively. JNK-IN-11 has the potential for the research of alzheimer and parkinson disease[1].
Product Specifications
CAS Number
[676594-38-0]
UNSPSC
12352005
Target
JNK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/jnk-in-11.html
Purity
98.01
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(NC(CC2=CC=CS2)=O)C=CS1)OC
Molecular Formula
C12H11NO3S2
Molecular Weight
281.35
References & Citations
[1]Hom RK, et al. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK. Bioorg Med Chem Lett. 2010 Dec 15;20 (24) :7303-7.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JNK1; JNK2; JNK3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6321389-01 0.1 mL
MMP17, CT (MMP17, MT4MMP, Matrix metalloproteinase-17, Membrane-type matrix metalloproteinase 4, Membrane-type-4 matrix metalloproteinase) (MaxLight 490)
Ask
View Details MBS6321389-02 5x 0.1 mL
MMP17, CT (MMP17, MT4MMP, Matrix metalloproteinase-17, Membrane-type matrix metalloproteinase 4, Membrane-type-4 matrix metalloproteinase) (MaxLight 490)
Ask
View Details 
GTR15388136 1 Vial
Lentiviral human EIF2AK2 sgRNA gene knockout kit - Lentiviral human EIF2AK2 sgRNA gene knockout kit (plasmid)
Ask
View Details 
GTR15351364 1 Vial
Lentiviral human SOX14 shRNA (UAS) - Lentiviral human SOX14 shRNA (UAS, RFP) plasmid
Ask
View Details